table of content
1 Introduction to Research & Analysis Reports
1.1 Cellular and Gene Therapy Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cellular and Gene Therapy Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cellular and Gene Therapy Product Overall Market Size
2.1 Global Cellular and Gene Therapy Product Market Size: 2022 VS 2029
2.2 Global Cellular and Gene Therapy Product Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cellular and Gene Therapy Product Players in Global Market
3.2 Top Global Cellular and Gene Therapy Product Companies Ranked by Revenue
3.3 Global Cellular and Gene Therapy Product Revenue by Companies
3.4 Top 3 and Top 5 Cellular and Gene Therapy Product Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cellular and Gene Therapy Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cellular and Gene Therapy Product Players in Global Market
3.6.1 List of Global Tier 1 Cellular and Gene Therapy Product Companies
3.6.2 List of Global Tier 2 and Tier 3 Cellular and Gene Therapy Product Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cellular and Gene Therapy Product Market Size Markets, 2022 & 2029
4.1.2 Cellular Immunotherapies
4.1.3 Cancer Vaccines
4.1.4 Autologous and Allogeneic Cells
4.2 By Type - Global Cellular and Gene Therapy Product Revenue & Forecasts
4.2.1 By Type - Global Cellular and Gene Therapy Product Revenue, 2018-2023
4.2.2 By Type - Global Cellular and Gene Therapy Product Revenue, 2024-2029
4.2.3 By Type - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cellular and Gene Therapy Product Market Size, 2022 & 2029
5.1.2 Blood Cancer
5.1.3 Prostate Cancer
5.1.4 Skin Cancer
5.1.5 Other
5.2 By Application - Global Cellular and Gene Therapy Product Revenue & Forecasts
5.2.1 By Application - Global Cellular and Gene Therapy Product Revenue, 2018-2023
5.2.2 By Application - Global Cellular and Gene Therapy Product Revenue, 2024-2029
5.2.3 By Application - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cellular and Gene Therapy Product Market Size, 2022 & 2029
6.2 By Region - Global Cellular and Gene Therapy Product Revenue & Forecasts
6.2.1 By Region - Global Cellular and Gene Therapy Product Revenue, 2018-2023
6.2.2 By Region - Global Cellular and Gene Therapy Product Revenue, 2024-2029
6.2.3 By Region - Global Cellular and Gene Therapy Product Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cellular and Gene Therapy Product Revenue, 2018-2029
6.3.2 US Cellular and Gene Therapy Product Market Size, 2018-2029
6.3.3 Canada Cellular and Gene Therapy Product Market Size, 2018-2029
6.3.4 Mexico Cellular and Gene Therapy Product Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cellular and Gene Therapy Product Revenue, 2018-2029
6.4.2 Germany Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.3 France Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.4 U.K. Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.5 Italy Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.6 Russia Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.7 Nordic Countries Cellular and Gene Therapy Product Market Size, 2018-2029
6.4.8 Benelux Cellular and Gene Therapy Product Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cellular and Gene Therapy Product Revenue, 2018-2029
6.5.2 China Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.3 Japan Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.4 South Korea Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.5 Southeast Asia Cellular and Gene Therapy Product Market Size, 2018-2029
6.5.6 India Cellular and Gene Therapy Product Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cellular and Gene Therapy Product Revenue, 2018-2029
6.6.2 Brazil Cellular and Gene Therapy Product Market Size, 2018-2029
6.6.3 Argentina Cellular and Gene Therapy Product Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cellular and Gene Therapy Product Revenue, 2018-2029
6.7.2 Turkey Cellular and Gene Therapy Product Market Size, 2018-2029
6.7.3 Israel Cellular and Gene Therapy Product Market Size, 2018-2029
6.7.4 Saudi Arabia Cellular and Gene Therapy Product Market Size, 2018-2029
6.7.5 UAE Cellular and Gene Therapy Product Market Size, 2018-2029
7 Cellular and Gene Therapy Product Companies Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Major Product Offerings
7.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 New York Blood Center
7.2.1 New York Blood Center Company Summary
7.2.2 New York Blood Center Business Overview
7.2.3 New York Blood Center Cellular and Gene Therapy Product Major Product Offerings
7.2.4 New York Blood Center Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.2.5 New York Blood Center Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Cellular and Gene Therapy Product Major Product Offerings
7.3.4 Johnson & Johnson Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Cleveland Cord Blood Center
7.4.1 Cleveland Cord Blood Center Company Summary
7.4.2 Cleveland Cord Blood Center Business Overview
7.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Major Product Offerings
7.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.4.5 Cleveland Cord Blood Center Key News & Latest Developments
7.5 Organogenesis
7.5.1 Organogenesis Company Summary
7.5.2 Organogenesis Business Overview
7.5.3 Organogenesis Cellular and Gene Therapy Product Major Product Offerings
7.5.4 Organogenesis Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.5.5 Organogenesis Key News & Latest Developments
7.6 Duke University School of Medicine
7.6.1 Duke University School of Medicine Company Summary
7.6.2 Duke University School of Medicine Business Overview
7.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Major Product Offerings
7.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.6.5 Duke University School of Medicine Key News & Latest Developments
7.7 Colorado Cord Blood Banking
7.7.1 Colorado Cord Blood Banking Company Summary
7.7.2 Colorado Cord Blood Banking Business Overview
7.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Major Product Offerings
7.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.7.5 Colorado Cord Blood Banking Key News & Latest Developments
7.8 MD Anderson Cancer Center
7.8.1 MD Anderson Cancer Center Company Summary
7.8.2 MD Anderson Cancer Center Business Overview
7.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Major Product Offerings
7.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.8.5 MD Anderson Cancer Center Key News & Latest Developments
7.9 LifeSouth Community Blood Centers
7.9.1 LifeSouth Community Blood Centers Company Summary
7.9.2 LifeSouth Community Blood Centers Business Overview
7.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Major Product Offerings
7.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.9.5 LifeSouth Community Blood Centers Key News & Latest Developments
7.10 Bloodworks Northwest
7.10.1 Bloodworks Northwest Company Summary
7.10.2 Bloodworks Northwest Business Overview
7.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Major Product Offerings
7.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.10.5 Bloodworks Northwest Key News & Latest Developments
7.11 Amgen
7.11.1 Amgen Company Summary
7.11.2 Amgen Business Overview
7.11.3 Amgen Cellular and Gene Therapy Product Major Product Offerings
7.11.4 Amgen Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.11.5 Amgen Key News & Latest Developments
7.12 Novartis Pharmaceuticals
7.12.1 Novartis Pharmaceuticals Company Summary
7.12.2 Novartis Pharmaceuticals Business Overview
7.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Major Product Offerings
7.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.12.5 Novartis Pharmaceuticals Key News & Latest Developments
7.13 Castle Creek Biosciences
7.13.1 Castle Creek Biosciences Company Summary
7.13.2 Castle Creek Biosciences Business Overview
7.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Major Product Offerings
7.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.13.5 Castle Creek Biosciences Key News & Latest Developments
7.14 Spark Therapeutics
7.14.1 Spark Therapeutics Company Summary
7.14.2 Spark Therapeutics Business Overview
7.14.3 Spark Therapeutics Cellular and Gene Therapy Product Major Product Offerings
7.14.4 Spark Therapeutics Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.14.5 Spark Therapeutics Key News & Latest Developments
7.15 Vericel
7.15.1 Vericel Company Summary
7.15.2 Vericel Business Overview
7.15.3 Vericel Cellular and Gene Therapy Product Major Product Offerings
7.15.4 Vericel Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.15.5 Vericel Key News & Latest Developments
7.16 Dendreon Pharmaceuticals
7.16.1 Dendreon Pharmaceuticals Company Summary
7.16.2 Dendreon Pharmaceuticals Business Overview
7.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Major Product Offerings
7.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.16.5 Dendreon Pharmaceuticals Key News & Latest Developments
7.17 Enzyvant Therapeutics GmbH
7.17.1 Enzyvant Therapeutics GmbH Company Summary
7.17.2 Enzyvant Therapeutics GmbH Business Overview
7.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Major Product Offerings
7.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.17.5 Enzyvant Therapeutics GmbH Key News & Latest Developments
7.18 Mallinckrodt
7.18.1 Mallinckrodt Company Summary
7.18.2 Mallinckrodt Business Overview
7.18.3 Mallinckrodt Cellular and Gene Therapy Product Major Product Offerings
7.18.4 Mallinckrodt Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.18.5 Mallinckrodt Key News & Latest Developments
7.19 Gilead Sciences
7.19.1 Gilead Sciences Company Summary
7.19.2 Gilead Sciences Business Overview
7.19.3 Gilead Sciences Cellular and Gene Therapy Product Major Product Offerings
7.19.4 Gilead Sciences Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.19.5 Gilead Sciences Key News & Latest Developments
7.20 bluebird bio
7.20.1 bluebird bio Company Summary
7.20.2 bluebird bio Business Overview
7.20.3 bluebird bio Cellular and Gene Therapy Product Major Product Offerings
7.20.4 bluebird bio Cellular and Gene Therapy Product Revenue in Global Market (2018-2023)
7.20.5 bluebird bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
